China Unveils Latest Five-Year Plans For Pharma And Medical Device Industries (Part 1 of 2)
This article was originally published in PharmAsia News
China’s ambitious five-year plans will support policies to increase domestic R&D and import substitution for China’s biopharma and medical device industries.
You may also be interested in...
China Kanghui has emerged as one of the leaders in China’s orthopedics industry, building a business first on trauma and, more recently, spine. Now, with a pending move into reconstruction, the company is looking to other emerging markets, and eventually the US and Europe.
[Editor's note: This is part two of a two-part story. Part one appeared in PharmAsia News, Feb. 22, 2011.]
U.S.-listed orthopedic device maker Zimmer Inc. says its latest overseas purchase of Beijing Montagne Medical Device Co. Ltd., gives it greater marketing access to the Chinese orthopedic implant market, growing at an estimated 15 percent annually, and a manufacturing base to compete with rivals already in the market